The DOI matches its Crossref record.
Update version of the Japanese Guidelines for Gastric Cancer Screening
Abstract
BACKGROUND: Although the incidence and mortality of gastric cancer have gradually decreased, its burden remains in East Asian countries. Gastric cancer screening has been performed in Japan since 1983, and the introduction of new screening techniques has been eagerly anticipated. OBJECTIVE: To promote evidence-based screening, the Japanese guidelines for gastric cancer screening have been revised based on the new studies. METHODS: The guidelines for gastric cancer screening have been developed according to a previously established method. To assess evidence regarding the effectiveness of the screening methods, a systematic review was conducted based on an analytic framework including clinical questions aiming at reducing mortality from gastric cancer. The following methods were assessed for gastric cancer screening: upper gastrointestinal series (radiographic screening), gastrointestinal endoscopy (endoscopic screening), Helicobacter pylori antibody test and serum pepsinogen tests. Based on the balance of the benefits and harms of each screening method, recommendations for population-based and opportunistic screenings were formulated. FINDINGS: After the Japanese guidelines for gastric cancer screening were published in 2005, several observational studies on radiographic and endoscopic screenings have been reported. Three case-control studies have evaluated mortality reduction from gastric cancer by endoscopic screening. Notably, evidence of the H. pylori antibody and serum pepsinogen tests was insufficient. Although false-positive results, false-negative results, and complications were observed in endoscopic and radiographic screenings, the complication rates were higher in endoscopic screening than in radiographic screening. Overdiagnosis was not estimated directly in both methods. RECOMMENDATIONS: Radiographic and endoscopic screenings for gastric cancer are recommended for population-based and opportunistic screenings. The H. pylori antibody and serum pepsinogen tests are not recommended for population-based screening because of insufficient evidence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Global Burden of 5 Major Types of Gastrointestinal Cancer
Arnold, M., Abnet, C. C., Neale, R. E., Vignat, J., Giovannucci, E. L., McGlynn, K. A., & Bray, F. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.068 · Cited by 2,027
Epidemiology of gastric cancer: global trends, risk factors and prevention
Rawla, P., & Barsouk, A. (2019) · Gastroenterology Review · doi:10.5114/pg.2018.80001 · Cited by 1,540
Morgan, E., Arnold, M., Camargo, M. C., Gini, A., Kunzmann, A. T., Matsuda, T., Meheus, F., Verhoeven, R. H. A., Vignat, J., Laversanne, M., et al. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101404 · Cited by 773
Global burden of oesophageal and gastric cancer by histology and subsite in 2018
Arnold, M., Ferlay, J., van Berge Henegouwen, M. I., & Soerjomataram, I. (2020) · Gut · doi:10.1136/gutjnl-2020-321600 · Cited by 599
Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035
Arnold, M., Park, J. Y., Camargo, M. C., Lunet, N., Forman, D., & Soerjomataram, I. (2020) · Gut · doi:10.1136/gutjnl-2019-320234 · Cited by 504
Metadata
- Authors
- Hamashima, C., & Systematic Review Group and Guideline Development Group for Gastric Cancer Screening Guidelines
- Venue
- Japanese Journal of Clinical Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-06-08
- Volume
- 48
- Issue
- 7
- Pages
- 673-683
- ISSN
- 0368-2811 (ISSN-L)
- 1465-3621
- OpenAlex
- W2805161139
- Cited by
- 418
- References
- 0
- FWCI
- 24.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Update version of the Japanese Guidelines for Gastric Cancer Screening. https://app.cochat.ai/papers/10.1093/jjco/hyy077
- The paper
- Hamashima, C., & Systematic Review Group and Guideline Development Group for Gastric Cancer Screening Guidelines. (2018). Update version of the Japanese Guidelines for Gastric Cancer Screening. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyy077
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.